Clinical Impact of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Associated Clostridioides difficile Infection Among Patients with Lung Cancer

AIM: Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKIs)-associated Clostridioides difficile infection (CDI) among lung cancer patients have been reported in case reports and adverse events reporting system databases in the United States and Japan, but clinical data remained insuf...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Ying-Shan, Lin, Yu-Ching, Hung, Ming-Szu, Ho, Meng-Chin, Fang, Yu-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805707/
https://www.ncbi.nlm.nih.gov/pubmed/36597497
http://dx.doi.org/10.2147/OTT.S386807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805707/
https://www.ncbi.nlm.nih.gov/pubmed/36597497
http://dx.doi.org/10.2147/OTT.S386807

Ejemplares similares